Medication info
DuoMet XR Tablet 1000/10 mg

DuoMet XR Tablet 1000/10 mg

Prescription medicationTabletOralApproval revoked
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
PTP - 30 tablets/PTP [(10 tablets/PTP x 3)], Bottle - 30 tablets/bottle
Approval status
Approval revoked

MFDS item code 201905633 · Approved 2019.08.09 · Insurance code 645405560

This product's status changed to Approval revoked on 2026.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Substitution therapy for concomitant use of metformin and rosuvastatin
Who takes it
Adults
Adult dose
For adults only, administer once daily with the evening meal. For convenience, patients taking metformin hydrochloride and rosuvastatin calcium concomitantly may be switched to this medicine (a fixed-dose combination containing the same amounts of each active ingredient). The safety and efficacy of this medicine have been established at a metformin hydrochloride dose of 1500 mg.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Substitution therapy for concomitant use of metformin and rosuvastatin

View approved original text

This medication is used as combination replacement therapy for patients who need to take both Metformin Hydrochloride and Rosuvastatin Calcium simultaneously.

How to take

Adult dose

For adults only, administer once daily with the evening meal. For convenience, patients taking metformin hydrochloride and rosuvastatin calcium concomitantly may be switched to this medicine (a fixed-dose combination containing the same amounts of each active ingredient). The safety and efficacy of this medicine have been established at a metformin hydrochloride dose of 1500 mg.

Precautions

This medication can rarely cause a serious condition called lactic acidosis, which may lead to death, so caution is needed. When used with other blood glucose lowering medications, severe hypoglycemic symptoms may occur, requiring careful monitoring. Individuals allergic to the ingredients of this medication or similar drugs should not use it. Patients with severe liver dysfunction or those with liver disease should not take this medication. Individuals who have muscle disorders or are prone to muscle problems should avoid using this medication, especially at higher doses where the risk is greater. Patients with severely impaired kidney function, dehydration, serious infections, acute heart problems, etc., should not use this medication. This medication must be discontinued in cases of acute heart failure or before certain radiation tests, and it can be resumed once normal kidney function is confirmed post-examination. This medication is not appropriate for type 1 diabetes patients or those with diabetic ketoacidosis. Patients with severe infections, trauma, or those undergoing surgery should temporarily stop using this medication and can resume once their condition stabilizes. Extra caution is required for patients with very poor nutritional status or certain endocrine disorders when using this medication. This medication contains lactose, and individuals with lactose intolerance should not take it. Discontinuities in meal timing or insufficient food intake, as well as rigorous exercise, should be considered when using this medication. If symptoms of muscle pain or weakness occur, you should immediately inform your doctor and get evaluated, and discontinue use if necessary. Regular liver and kidney function tests should be performed while taking this medication, and it is particularly important for elderly patients or those with compromised kidney function to exercise further caution. Alcohol consumption during treatment should be avoided, as it may increase the risk of lactic acidosis. Women who are pregnant or may become pregnant should not take this medication and should use adequate contraception. Breastfeeding women are also advised not to take this medication. The safety and efficacy of this medication have not been established in children or adolescents under 19 years of age, and it should not be used in this population. In case of overdose, immediate medical attention should be sought, and blood dialysis or other treatment may be required. Care should be taken when driving or operating machinery, as dizziness may occur with this medication. This medication should be kept out of reach of children and stored in its original container to maintain quality.

Side effects

Severe lactic acidosis, severe hypoglycemia, diarrhea, epigastric pain, constipation, abdominal pain, belching, gastroesophageal reflux disease, upper abdominal discomfort, dyspepsia, cellulitis, sensory disturbances, arthralgia, papular rash, elevated creatine phosphokinase, elevated liver enzymes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, taste impairment, nausea, vomiting, abdominal pain, anorexia, erythema, itching, urticaria, angioedema, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory impairment, forgetfulness, amnesia, memory disorders, confusion, headache, dizziness, increased ALT, chest pain, cough, myalgia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, nausea, diarrhea, anorexia, abdominal distension, itching, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug's effectiveness and safety for an extended period.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

PTP - 30 tablets/PTP [(10 tablets/PTP x 3)], Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.